Expanding the Role of Suprachoroidal Injections - Top-Institutions - MDSpire

Expanding the Role of Suprachoroidal Injections

Clinical data support this targeted route for small molecules, gene therapy, and oncologic agents, with a good safety profile and potential to reduce treatment burden.

  • By

  • Thomas A. Ciulla, MD, MBA

  • September 1, 2025

  • 18 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Bascom Palmer Eye Institute, University of Miami
    Bascom Palmer Eye Institute, University of Miami

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Retina
    • Ocular Drug Delivery

  • #2

    Massachusetts Eye and Ear Infirmary, Harvard Medical School
    Massachusetts Eye and Ear Infirmary, Harvard Medical School

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Retina
    • Gene Therapy

  • #3

    Wills Eye Hospital
    Wills Eye Hospital

    Philadelphia, PA

    Key Differentiators

    • Ophthalmology
    • Retina
    • Clinical Trials

  • #4

    Johns Hopkins Wilmer Eye Institute
    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Retina
    • Ocular Pharmacology

  • #5

    Duke Eye Center
    Duke Eye Center

    Durham, NC

    Key Differentiators

    • Ophthalmology
    • Retina
    • Gene Therapy

Original Source(s)

Expanding the Role of Suprachoroidal Injections

  • by Thomas A. Ciulla, MD, MBA

  • September 1, 2025

Related Content

Myopia Severity Tied to Pediatric Retinal Pathology

Routine dilated examinations identified peripheral retinal abnormalities across refractive groups, with higher pathology rates among patients with at least 3.00 D of myopia

Immune-Mediated Inflammatory Diseases Following Pediatric Uveitis Diagnosis

The Art of Ophthalmology 2026

Showcasing artwork and images from across the spectrum of ophthalmology